EMA Seeks to Issue Guidance on Liver Damage From Gene Therapy EMA Seeks to Issue Guidance on Liver Damage From Gene Therapy

The European Medicines Agency said it plans to issue advice for physicians using Novartis AG ' s Zolgensma, calling on them to monitor patients for any liver injury after treatment.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news